Pharmacological preconditioning with lipopolysaccharide in the brain.
Deplanque
D
D
Bordet
R
R
D000818:Animals; D002545:Brain Ischemia / Q000517:prevention & control*; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism; D004790:Enzyme Induction / Q000187:drug effects; D005786:Gene Expression Regulation; D006360:Heat-Shock Proteins / Q000096:biosynthesis / Q000235:genetics; D019194:Ischemic Preconditioning; D008070:Lipopolysaccharides / Q000008:administration & dosage / Q000627:therapeutic use*; D017202:Myocardial Ischemia / Q000517:prevention & control; D009419:Nerve Tissue Proteins / Q000096:biosynthesis / Q000235:genetics; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D019001:Nitric Oxide Synthase / Q000096:biosynthesis / Q000235:genetics; D052250:Nitric Oxide Synthase Type III; D009928:Organ Specificity; D018384:Oxidative Stress; D011292:Premedication; D013482:Superoxide Dismutase / Q000096:biosynthesis / Q000235:genetics
D006360:Heat-Shock Proteins; D008070:Lipopolysaccharides; D009419:Nerve Tissue Proteins; D018696:Neuroprotective Agents; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III; D013482:Superoxide Dismutase